Skip to content

Clinical trials

Leukemia, Myelomonocytic, Chronic trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelomonocytic, Chronic Country / region: South Korea Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20071
20081
20092
20112
20161
20172
20191
20204
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting2
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asan Medical Center6
Novartis Pharmaceuticals2
Aptose Biosciences Inc.1
Astex Pharmaceuticals, Inc.1
Bristol-Myers Squibb1
Eli Lilly and Company1
Hemavant Sciences GmbH1
JW Pharmaceutical1
Janssen Research & Development, LLC1
Prelude Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelomonocytic, Chronic17
Leukemia, Myeloid, Acute14
Myelodysplastic Syndromes13
Blast Crisis5
Leukemia, Myeloid, Accelerated Phase5
Leukemia, Myeloid, Chronic-Phase5
Precursor Cell Lymphoblastic Leukemia-Lymphoma5
Congenital Abnormalities4
Leukemia4
Leukemia, Lymphocytic, Chronic, B-Cell4

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.